A Study of JNJ-54767414 (Daratumumab) in Combination With Bortezomib and Dexamethasone (D-Vd) in Japanese Participants With Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Bortezomib
Related studies linked through entity extraction aliases.
A Phase III Trial on the Effect of Elotuzumab in VRD Induction /Consolidation and Lenalidomide Maintenance in Patients With Newly Diagnosed Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
Trial of High Dose Melphalan/Stem Cell Transplant With or Without Bortezomib
- Status
- TERMINATED
- Phase
- PHASE3
Monitoring and Treatment of Relapsed Leukemia Following Allogeneic Hematopoietic Stem Cell Transplantation in Children
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trial of Expanded and Activated Autologous NK Cells to Treat Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Observational Study to Evaluate the Efficacy and Safety of Bortezomib, Melphalan, Prednisone (VMP) in Participants With Multiple Myeloma
- Status
- COMPLETED
- Phase
- N/A
Relapse Myeloma; Cyclofosfamide; Bortezomib; Maintenance
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Study of Efficacy and Safety of Lenalidomide, Subcutaneous Bortezomib and Dexamethasone Therapy for Newly Diagnosed Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Allogeneic Hematopoietic Stem Cell Transplantation With Ixazomib for High Risk Multiple Myeloma (BMT CTN 1302)
- Status
- COMPLETED
- Phase
- PHASE2
Optimising Renal Outcome in Myeloma Renal Failure
- Status
- COMPLETED
- Phase
- PHASE2
Bortezomib and Vorinostat in Younger Patients With Refractory or Relapsed MLL Rearranged Hematologic Malignancies
- Status
- TERMINATED
- Phase
- PHASE2
Study of Bortezomib,Lenalidomide,Dexamethasone & Elotuzumab in Newly Diagnosed MM
- Status
- COMPLETED
- Phase
- PHASE2
Comparing and Combining Bortezomib and Mycophenolate in SSc Pulmonary Fibrosis
- Status
- COMPLETED
- Phase
- PHASE2
CyBorD vs. PAD in the Treatment of Newly Diagnosed Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE3
Combination of Ibrutinib and Bortezomib to Treat Patients With Mantle Cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Melphalan and Bortezomib Prior to Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Bortezomib, Lenalidomide, and Dexamethasone in Treating Patients With Multiple Myeloma Undergoing Stem Cell Transplant
- Status
- TERMINATED
- Phase
- PHASE2
A Study of BBI608 in Adult Patients With Advanced, Refractory Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Bortezomib With Steroid Pulse Therapy for Acute Cellular Rejection in Kidney Transplantation
- Status
- UNKNOWN
- Phase
- PHASE3
Selinexor and Backbone Treatments of Multiple Myeloma Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2